Home > Clinical Development > LACTIN-V Publications

LACTIN-V Publications

LACTIN-V Publications

Publications Related to LACTIN-V or Lactobacillus crispatus CTV-05

• Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. Antonio MA, Meyn LA, Murray PJ, Busse B, Hillier SL. J Infect Dis. 199(10):1506-13, 2009.
• Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis. Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, Shiboski S, Cohen CR. Sex Transm Dis. 36(9):564-9, 2009.
• Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Czaja CA, Stapleton AE, Yarova-Yarovaya Y, Stamm WE. Infect Dis Obstet Gynecol 2007;2007:353878.
• Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection. Kwok L, Stapleton AE, Stamm WE, Hillier SL, Wobbe CL, Gupta K. J Urol. 176(5):2050-4, 2006.
• Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. Marrazzo JM, Cook RL, Wiesenfeld HC, Murray PJ, Busse B, Krohn M, Hillier SL. J Womens Health (Larchmt). 15(9):1053-60, 2006.
• Lactobacillus crispatus capsules: single-use safety study in the Macaca nemestrina model. Patton DL, Cosgrove Sweeney YT, Antonio MA, Rabe LK, Hillier SL. Sex Transm Dis. 30(7):568-70, 2003.
• DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization. Antonio MA, Hillier SL. J Clin Microbiol. 41(5):1881-7, 2003.

For Details, please visit http://www.ncbi.nlm.nih.gov/pubmed/